Concepedia

Ira Winer

IW

Statistics

Publications

44

Citations

2.6K

H-Index

23

Active since

2002

Affiliations

The Barbara Ann Karmanos Cancer Institute(Current)

Wayne State University

University of Michigan

Caris Life Sciences (United States)

University of South Alabama

Ira Winer is an author at The Barbara Ann Karmanos Cancer Institute specializing in oncology, medicine, and gynecologic oncology.

ORCID

Publications per year

2002–2025

44

Publications

44

Effective expression of small interfering RNA in human cells

Cynthia P. Paul, Paul D. Good, Ira Winer et al. · Nature Biotechnology · 2002 · 825 citations

, , +7

Berzosertib plus gemcitabine versus gemcitabine alone in platinum-resistant high-grade serous ovarian cancer: a multicentre, open-label, randomised, phase 2 trial

Panagiotis A. Konstantinopoulos, Su-Chun Cheng, Andrea E. Wahner Hendrickson et al. · The Lancet Oncology · 2020 · 232 citations · Full text

, , +13

A Phase III Study of Pafolacianine Injection (OTL38) for Intraoperative Imaging of Folate Receptor–Positive Ovarian Cancer (Study 006)

János L. Tanyi, Leslie M. Randall, Setsuko K. Chambers et al. · Journal of Clinical Oncology · 2022 · 166 citations · Full text

, , +17

ITF-2, a downstream target of the Wnt/TCF pathway, is activated in human cancers with β-catenin defects and promotes neoplastic transformation

Frank T. Kolligs, Marvin T. Nieman, Ira Winer et al. · Cancer Cell · 2002 · 157 citations · Full text

, , +17

Survival Benefit for Individuals With Constitutional Mismatch Repair Deficiency Undergoing Surveillance

Carol Durno, Ayse B. Ercan, Vanessa Bianchi et al. · Journal of Clinical Oncology · 2021 · 101 citations · Full text

, , +16

1–5 of 44